Related Experiment Video
Updated: Jun 29, 2025

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
Prognostic Factors in Prostate Cancer Associated with Ulcerative Colitis
Motoki Kaneko1, Yasuhiro Kanatani2, Hirohiko Sato1
1Division of Gastroenterology, Department of Internal Medicine, School of Medicine, Tokai University, 143 Shimokasuya, Isehara 259-1193, Japan.
Ulcerative colitis (UC) patients, particularly those with adult-onset or pancolitis-type UC, show a higher risk of prostate cancer (PCa). Biologics may potentially reduce PCa development in UC patients.
Area of Science:
- Gastroenterology
- Oncology
- Epidemiology
Background:
- Ulcerative colitis (UC) is linked to increased prostate cancer (PCa) risk, but underlying mechanisms and population-specific data, especially in Japan, are limited.
- Understanding these associations is crucial for managing UC patients and mitigating PCa risk.
Purpose of the Study:
- To investigate the association between UC and PCa risk in the Japanese population.
- To identify risk factors for PCa among older UC patients.
Main Methods:
- A retrospective single-center cohort study analyzing 68 UC patients between January 2010 and April 2022.
- Data included UC onset type, pancolitis status, treatment modalities (immunosuppressants, biologics), and PCa incidence.
Main Results:
- Nine out of 68 UC patients (13.2%) developed PCa.
- PCa incidence was higher in adult-onset UC (20.0%) compared to older-onset UC (3.57%).
- Pancolitis-type UC showed a trend towards higher PCa occurrence; biologics group had no PCa cases (p=0.07).
Conclusions:
- Adult-onset UC and pancolitis-type UC may be risk factors for PCa.
- Biologics might have a protective effect against PCa development in UC patients, warranting further investigation.
More Related Videos
15:49Flexible Colonoscopy in Mice to Evaluate the Severity of Colitis and Colorectal Tumors Using a Validated Endoscopic Scoring System
Published on: October 16, 2013
06:24Author Spotlight: Liujunzi Decoction as a Traditional Chinese Treatment for Coloproctitis Cancer
Published on: October 13, 2023
Related Concept Videos
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
Peptic Ulcer Disease I: Introduction
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Drugs for Treatment of Ulcerative Colitis in IBD